Numerous ethnomedicinal uses have been attributed to different parts of
Medicinal plants contain potentially useful chemical compounds that serve as the basis for manufacturing modern medicines (1). In recent years, the clinical value of herbal medicines has received considerable attention. Plant poisoning of animals is a common phenomenon (2,3); some medicinal plants may produce long-term adverse effects such as hepatotoxicity and nephrotoxicity (4). The importance of the active ingredients of plants in agriculture and medicine has stimulated marked scientific interest in the biological activities of these substances (5). One such plant with an abundance of phytochemicals is
ASE is a shrub or small tree about 2–6 m tall; it is mostly found in the savanna and parts of the tropical rainforest regions. It is also found in several African countries, including Senegal, Nigeria, Cape Verde, Sudan, and South Africa and is especially common in northern Nigeria, primarily in Nasarawa, Kaduna, Kano, Plateau, Niger, and Abuja (6). It is commonly known as African custard apple, wild custard apple, and wild soursop (7,8) and has aromatic flowers, which are used to flavor food. The ripe fruit is yellow in color and has a sweet edible jelly with a pleasant odor and pineapple-like taste. The ASE fruit has many local names and is commonly known as “Uburu ocha” (Igbo), “gwandar daajii” (Hausa), “arere” or “abo” (Yoruba), “Ukpokpo” (Igala), “ngonowu” (Kanuri), “uwu” (Idoma), and “mkonokono” (Swahili) (9). It is widely used in ethnomedicine for the treatment of different types of ailments and as such enjoys a great reputation for its immense ethnomedicinal value. ASE extract has been reported to have antibacterial (10) and antidiarrheal activities (11). Furthermore, its whole root extract has been reported to have anticonvulsant effects (12) and has been investigated for analgesic, anti-inflammatory (13,14), trypanocidal (15,16), and anti-snake venom activities (9). Essential oils from the leaves (linalool) and fruits (car-3-ene) of ASE have also exhibited antibacterial activity (17). Further, ASE decoction is used in the treatment of sleeping sickness in northern Nigeria (18); it is also used for the treatment of cancer (19,20) and malarial infection (21) in folk medicine. Recently, anticonvulsant, muscle relaxant, and sedative effects of ASE root bark extract were reported (22). Neuropharmacological, antioxidant, and hepatoprotective activities of ASE leaf extract have also been reported (23,24). The stem bark of ASE has traditionally been used for the treatment of snake bite, hernia, and open sores (25,26). It has also been reported to possess antimicrobial and anti-trypanosomal properties (27). Terpeneand flavonoid-containing essential oils with antimicrobial activity have also been isolated from the stem bark of ASE (28,29). Nevertheless, compared to the literature on the other parts of the plant (30), there is a dearth of scientific evidence-based information on the pharmacological and toxicological activities of ASE stem bark. Thus, in the present study, we investigated the hepatotoxicity and antioxidant potential of ASE stem bark extracts administered to Wistar strain albino rats for 28 days.
The following chemicals used for this experiment were of analytical grade and purchased from Sigma Aldrich: 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), mannitol, potassium hydroxide, bovine serum albumin, potassium chloride, sodium potassium tartrate, sodium succinate, sodium bicarbonate, and 5% trichloroacetic acid. N-Hexane, ethanol, and 10% formalin were from Thermo Fisher Scientific (Loughborough, UK). Other reagents and chemicals used were of analytical grade.
Fresh stem barks of the ASE plant were collected and authenticated at the herbarium of the Botany department of the University of Lagos (Voucher number LuH 6184). The stems were dried on a laboratory tray for about 2 weeks after which the barks were peeled off and dried further in an oven at 40°C for about 12 hr until they were completely dry. The dried barks were milled into a powder and defatted with nhexane by using a Soxhlet apparatus. The marc obtained was allowed to dry before subsequent extraction with 95% ethanol by using the Soxhlet apparatus. The extract solution obtained was evaporated at 45°C by using a rotary evaporator and the residue, ASE extract, was collected and weighed.
Forty male Wistar strain albino rats weighing 120–150 g were obtained from the Animal House, College of Medicine, University of Lagos, Nigeria, and were kept in well-ventilated standard plastic cages. The rats were acclimatized for a period of 2 weeks and maintained on standard rat pellets (Pfizer Livestock Feeds, Lagos, Nigeria) and water
The acute toxicity and lethality of ASE extract were determined using the method described by Lorke (31). Briefly, twelve male rats were randomly divided into four groups (I, II, III, and IV; n = 3 per group) and were orally administered distilled water, and 500, 1,000, and 2,000 mg/kg ASE, respectively. The animals were observed at 2, 6, 12, and 24 hr for behavioral changes, itching, pupil dilation, and death.
Twenty male rats were divided into four groups of five rats each (A, B, C, and D). Male rats solely were used in this study of the toxicological or toxicokinetic properties of the compounds because they are likely to be more sensitive than females would be due to hormonal influences (32). Animals in group A (control) received 10 mL/kg body weight of normal saline, and groups B, C, and D were given 50, 100, and 150 mg/kg body weight of ASE. The extract was prepared fresh each morning and administered through oral gavage for 28 days. The initial weights of the animals were recorded just before extract administration and before sacrifice on day 29. The rats were fasted overnight before they were sacrificed by cervical dislocation and were dissected to excise the liver and kidneys. The tissues were rinsed in 1.15% KCl, blotted, and weighed immediately after excision.
Whole blood samples were obtained by retro-orbital puncture using capillary tubes just before sacrifice. The samples were collected in labeled lithium heparinized bottles for hematological profile analysis and in ethylene diamine tetraacetic acid anti-coagulated bottles for blood chemistry assays. Plasma was obtained by spinning whole blood samples for 10 min at 4,000 rpm in a Cencom Bench centrifuge. The supernatant (plasma) obtained was separated and kept frozen for the estimation of total protein (TP), alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST) activities as well as levels of bilirubin, urea, and creatinine. A portion of the weighed liver and kidney were separately maintained using 10% buffered-formaldehyde (formalin) solution to preserve the tissues for histopathological evaluation.
Hematological parameters including red blood cell count, white blood cell count, packed cell volume, hemoglobin level, lymphocyte count, and neutrophil count were determined using the BC-3200 Auto Hematology analyzer, (Mindray Medical International Ltd, Shenzhen, China).
The other portion of the excised liver and second kidney from the rats were washed separately with 1.15% KCl several times to remove blood, blotted, weighed, and suspended in 0.25 M sucrose (ice-cold) to prepare a 5% homogenate with a Potter-Elvehjem glass homogenizer. The kidney homogenate was aliquoted and stored at −80°C until required for use. The liver homogenate was centrifuged in a cold MSE centrifuge at 2,300 rpm for 5 min to separate the nuclear fraction and cell debris. Mitochondria were pelleted from the supernatant obtained by centrifugation at 12,000 rpm for 15 min. The supernatant (post-mitochondrial fraction [PMF]) obtained was aliquoted and kept frozen while the mitochondrial pellets were washed twice with sucrose buffer at 10,000 rpm for 15 min each time. The washed mitochondria were immediately resuspended in 0.25 M sucrose buffer, aliquoted, and kept frozen at −80°C (33) until use.
Plasma ALP, ALT, and AST activities, and urea, creatinine, and direct bilirubin levels were determined using the Roche Hitachi 912 Chemistry Auto-Analyzer (GMI Inc., MN, USA).
Succinate dehydrogenase (SDH) activity in isolated mitochondria was assayed using the method described by King (34). Briefly, the reaction mixture containing 0.2M phosphate buffer, pH 7.8 (0.375 mL), 0.045M KCN (0.05 mL), 0.6 M succinate (0.1 mL), 0.0015 M dichlorophenolindophenol (DCIP, 0.05 mL), 0.009 M phenazine methosulfate (PMS, 0.15 mL), and distilled water (2.95 mL) was added into a 4-mL spectrophotometer glass cuvette. The reaction was started by the addition of 0.05 mL of mitochondrial suspension. The change in absorbance at 600 nm (Δ600 nm) was recorded at 1-min intervals by using a Beckman DU-640 spectrophotometer. The Δ600 nm was converted to mmols of succinate oxidized by multiplying Δ600 nm by 0.0476. Enzyme activity was expressed as nmol succinate oxidized/min and specific activity as units/mg of mitochondrial protein.
Mitochondrial membrane phospholipid concentrations were determined as described by Chen
Superoxide dismutase (SOD) activity was determined by its ability to inhibit the auto-oxidation of epinephrine at pH 10.2 and was monitored based on an increase in absorbance at 480 nm as described by Misra and Fridovich (37). The activity of mitochondrial MnSOD was measured in the presence of 1 mM KCN, and the cytosolic (PMF) Cu, Zn, and SOD activities were determined in the absence of KCN (38). One unit of SOD activity was defined as the amount of enzyme required for 50% inhibition of the oxidation of epinephrine to adrenochrome at 480 nm min−1. The reaction mixture (3 mL) contained 2.5 mL of 0.05 M sodium carbonate buffer (pH 10.2); 0.2 mL of kidney homogenate, PMF, or mitochondria (1:10) (containing SOD); and 0.3 mL of 0.3 mM epinephrine used to initiate the reaction. The reference cuvette contained 2.5 mL of buffer, 0.3 mL of substrate (epinephrine), and 0.2 mL of water. Enzyme activity was determined by measuring the change in absorbance at 480 nm for 5 min.
Reduced glutathione (GSH) level was determined using Ellman’s reagent, 5,5
Catalase (CAT) activity was determined as described by Sinha (41). The sample (0.1 mL) was mixed with 4.9 mL of distilled water. The assay mixture contained 4 mL of 0.2 M H2O2 and 5 mL of 0.01 M phosphate buffer in a 10-mL flat bottom flask. One milliliter (1 mL) of the earlier diluted mitochondria, PMF, or kidney homogenate was rapidly mixed with the reaction mixture by gentle swirling motion at room temperature. The assay mixture (1 mL) was added to a test tube containing 2 mL of dichromate/acetic acid reagent at 60-s intervals for 3 min and heated for 10 min in boiling water. The mixture was allowed to cool and the absorbance was measured with a spectrophotometer at 570 nm.
The extent of lipid peroxidation in mitochondrial fractions and PMFs was determined using standard methods described by Buege and Aust (42) as follows. An aliquot of 0.4 mL of the mitochondria, PMF, and kidney homogenate was mixed with 1.6 mL of Tris KCl buffer. Then 0.5 mL of 30% TCA was added followed by 0.5 mL of 0.75% TBA and the mixture was placed in a water bath for 1 hr at a temperature of 90–95°C. Then, the mixture was cooled using ice and centrifuged at 3,000 rpm for 15 min. The clear pink supernatant was collected and absorbance was measured against a reference blank of distilled water at 532 nm by using a spectrophotometer.
A portion of liver and kidney tissues from each group was collected and preserved in 10% neutral-buffered formalin for histopathological studies. The tissues were processed and embedded in paraffin wax and thin sections (thickness, 5–6 μm) of liver tissue were cut before staining with hematoxylin and eosin. These thin sections of liver and kidney were made into permanent slides and examined photomicroscopically.
Data were statistically computed using Graph Pad Prism 6 Software (Graphpad Software Inc., CA, USA) and expressed as mean ± SEM values. Differences between mean values were further analyzed using Tukey Honest Significant Difference (Tukey’s HSD) test and values of
The median lethal dose (LD50) was > 2,000 mg/kg as no death was recorded after 24 hr, as shown in Table 1, for the ethanol extract of ASE and there were no abnormal behavioral activities.
Table 2 shows the effects of 28 days of oral administration of ASE on body weight gain and relative organ weights of male Wistar rats. The percentage body weight gain of the rats after 28 days of oral administration with ASE indicates that the animals gained weight but the percentage weight gain decreased as the doses of ASE administered increased. In fact, the rats administered 150 mg/kg ASE showed only a 0.56% increment in their weights compared to 19.4 and 17.5% weight gain shown by the animals treated with 50 and 100 mg/kg ASE, respectively. However, compared to the controls, rats administered different doses of ASE over the 28 days period showed no significant (
The biochemical indices in the plasma of Wistar rats administered ASE for 28 days are as presented in Table 3. Concentration-dependent increases were observed in the activities of ASP, ALT, and ALP and bilirubin levels. Significant increases (
The hematological profile of the rats treated with ASE is shown in Table 4. Compared to the control group, the groups that received 150 mg/kg body weight of ASE showed a significant increase (
Table 5 shows the activity of SDH and the concentrations of mitochondrial membrane macromolecules after 28 days of ASE extract administration
Levels of antioxidant parameters, including SOD, CAT, MDA, and GSH, in the liver mitochondria and PMFs are presented in Table 6, 7, respectively. The levels of GSH in the mitochondria of the extract-treated rats were not significantly (
Table 8 shows the data obtained from the evaluation of antioxidant parameters in the kidneys of rats that orally received ethanol extracts of ASE for 28 days. There was no significant (
Fig. 1, 2 are photomicrographs of liver and kidney sections, respectively, of rats treated with the ethanol extract of ASE
Medicinal plants are an important source of bioactive compounds and are used worldwide in traditional medicine for the treatment of various ailments. Although medicinal plants may have biological activities that are beneficial to humans, the potential toxicity of these bioactive substances has not been well established (43). Moreover, despite the widespread use, few scientific studies have been undertaken to ascertain the safety and efficacy of traditional remedies (44). Thus, the safety of these plants needs to be continuously studied thoroughly to avoid potential toxicity in humans. To this end, the present study evaluated the possible subacute toxic effects of ethanolic stem bark extracts of ASE, which is used in natural medicine in many African countries to alleviate many pathological conditions alone or in combination with other medicinal plants by traditional healers.
Acute toxicity tests are generally the first tests conducted in any toxicity study. They provide data on the relative toxicity likely to develop from a single brief exposure to any substance. Different plants extracts comprise different levels of bioactive compounds inherent in the plants (45). To evaluate the safety margin of ASE, an acute toxicity study was conducted and the LD50 of this extract was investigated at doses up to 2,000 mg/kg (26) based on previously reported data on safe doses of other parts of this plant, which were greater than 5,000 mg/kg. However, it became important to investigate a lower concentration because the intended subacute toxicity study was at a far lower dose. The LD50 of the stem bark extract of ASE was found to be greater than 2,000 mg/kg and no behavioral changes were observed (Table 1). This finding correlates with those of Okoye
Subacute toxicity studies provide information on dosage requirement and target organ toxicity and help identify observable adverse effects affecting the average lifespan of experimental animals. Body weight changes serve as sensitive indications of the general health status of animals (47,48). They have also been used as an indicator of adverse effects of drugs and chemicals (49). If body weight loss is more than 10% of the initial weight, it is considered statistically significant in the animal (50,51). In this study, the rats gained weight over the 28-day oral administration period of ASE extract (50–150 mg/kg). However, this weight gain decreased in a concentration-dependent manner as the extract doses increased. Indeed, the animals treated with 150 mg/kg of ASE extract barely gained about 1% weight during the administration period (Table 2). This finding is a sign of toxicity attributable to the ASE extract, which might be involved in appetite suppression in the rats administered this extract dose, which consequently may lead to a reduction in weight. Organ weight is also an important index of physiological and pathological status. Relative organ weight is usually used to evaluate organ injury (52) in terms of atrophy, hypertrophy, or swelling (53,54). Primarily, the liver and kidneys are prone to adverse effects during biotransformation of toxicants (54). In this study, the relative weights of the liver and kidneys of the ASE extract-treated rats were not significantly different (
Liver enzymes including ALT, AST, and ALP are useful diagnostic biomarkers of liver damage usually found in large quantities in the plasma or serum when hepatic cellular membrane permeability changes or when necrosis and cellular injury occurs (55). ALP activity and plasma bilirubin levels were significantly increased (
Furthermore, the significant increase in white blood cell counts at the dose of 150 mg/kg is indicative of stimulation of the immune system, although without an increase in the differentials. Thus, the possible non-allergic nature of the extract or its immune system-stimulating effects may be attributable to secondary infection; this finding is in agreement with those of Adebayo
SDH is a mitochondrial enzyme complex involved in the oxidation of succinate to fumarate in the Krebs cycle. This enzyme feeds electrons from this cycle into the ubiquinone pool in the respiratory chain (61) and together with ubiquinol has been implicated as a powerful antioxidant in mitochondria (62). The significant increase in SDH activity observed at the 150 mg/kg dose implies that ASE could be responsible for the induction and expression of SDH, support electron transfer, and ultimately increase ATP production in mitochondria. Many of the inner mitochondrial membrane proteins are involved in oxidative phosphorylation and their activity depends on the phospholipid composition of the membrane. Altered phospholipid composition affects mitochondrial respiration (63), as has been implicated in a variety of human diseases including Barth syndrome, ischemia, heart failure (64,65), and hepatotoxicity (66). ASE extract administration did not significantly compromise mitochondrial membrane cholesterol and phospholipids (Table 5). Nevertheless, the 50 mg/kg dose increased membrane cholesterol levels, which may suggest ASE to be steroidogenic at low concentrations.
An assessment of the antioxidant status of the rat liver and kidneys upon subacute administration of ASE extract was attempted by determining the activities of CAT and SOD, and levels of GSH and MDA. Oxidative stress is caused by the presence of reactive oxygen species (ROS) in excess of the available antioxidant buffering capacity (67). Many studies have shown that ROS can damage lipids, proteins, and DNA, thus altering the structures and functions of the cell, tissue, organ, and system, respectively (68). The cellular antioxidant buffering system includes factors such as SOD, CAT, GSH, GSH peroxidase and reductase, uric acid, and vitamin E. SOD is an effective defense enzyme that catalyzes the dismutation of superoxide anions into hydrogen peroxide (H2O2). CAT is a hemeprotein in aerobic cells that catalyzes the conversion of H2O2 into oxygen and water. It protects the tissue from oxidative damage by highly reactive oxygen free radicals and hydroxyl radicals (69). GSH is an extremely efficient intracellular buffer for oxidative stress; it acts as a non-enzymatic antioxidant that reduces H2O2, hydroperoxides (ROOH), and xenobiotic toxicity (70). Lipid peroxides or other ROS inactivate the antioxidant defense system, which results in reduced activities of antioxidant enzymes and an increase in the level of MDA (71). Findings from this study showed a significant dose-dependent increase (
In this study, the histopathology of the liver revealed that concentration-dependent localized degeneration of hepatic microarchitecture, characterized by slight necrosis in the perivenular area to a distinct but non-patterned mild and eventually severe necrosis at the perivenular and lobular areas, which were attributable to the 28-day oral administration of 50, 100 and 150 mg/kg of ASE stem bark extract, respectively (Fig. 1). This gradual morphological damage confirms the dose-response-related results of body weight, ALT and ALP levels, and antioxidant parameters. These data vary from those reported by Okoye
The findings from this study demonstrate that ASE stem bark extract induced oxidative damage to the liver microarchitecture and the chain of electron transfer in the mitochondria with prolonged ingestion. However, the extract had little or no toxic effects on the kidneys. Therefore, it is recommended that consumption of ASE should be reduced to the barest minimum and awareness should be created among the communities that consume any part of this plant.
Fig. 1. Photomicrographs of representative liver sections from rats administered ethanol extracts of ASE for 28 days as follows: (A) Control (normal saline) showing normal liver architecture. (B) 50 mg/kg ASE indicating slight focal area of perivenular necrosis. (C) 100mg/kg ASE showing clear and distinct but non-patterned mild area of necrosis. (D) 150 mg/kg ASE showing severe necrosis at the perivenular and lobular areas. Hematoxylin and eosin stained. Magnification X10.
Fig. 2. Photomicrographs of representative kidney sections from rats administered ethanol extracts of ASE for 28 days as follows: (A) Control (normal saline) showing normal kidney architecture in rats administered (B) 50, 100 and 150 mg/kg ASE. (C) 100 mg/kg and (D) 150mg/kg. Hematoxylin and eosin stained. Magnification X10.
Mean mortality during acute exposure to ethanol extract of
| Treatment | Death/Live ratio |
|---|---|
| I | 0/3 |
| II | 0/3 |
| III | 0/3 |
| IV | 0/3 |
LD50 value of ethanol extract of stem bark extracts of
Effect of 28 days oral administration of
| Treatments | % Weight gain | Relative weight (g/g) | |
|---|---|---|---|
| Liver | Kidney | ||
| A | 20.0 | 0.033 ± 0.001 | 0.0062 ± 0.0006 |
| B | 19.40 | 0.028 ± 0.002 | 0.0059 ± 0.0005 |
| C | 17.49 | 0.030 ± 0.002 | 0.0058 ± 0.0007 |
| D | 0.56* | 0.031 ± 0.007 | 0.0067 ± 0.0015 |
Data are expressed as mean ± standard deviation. ASE =
Biochemical parameters in the plasma of Wistar rats administered
| Parameters | Groups | |||
|---|---|---|---|---|
| A | B | C | D | |
| AST (U/L) | 205.4 ± 5.8 | 176.8 ± 7.4 | 203.0 ± 30.9 | 231.5 ± 25.6* |
| ALT (U/L) | 56.9 ± 6.3 | 42.5 ± 3.56 | 66.8 ± 19.2 | 81.9 ± 19.0* |
| ALP (U/L) | 164.9 ± 9.7 | 158.4 ± 17.2 | 179.0 ± 42.9* | 236.8 ± 50.3 |
| BIL (μmol/L) | 0.98 ± 0.2 | 0.90 ± 0.20 | 1.04 ± 0.21 | 1.24 ± 0.3* |
| CREAT (μmol/L) | 38.6 ± 2.5 | 41.4 ± 1.9 | 41.9 ± 2.83 | 40.7 ± 2.3 |
| UREA (mmol/L) | 7.18 ± 0.4 | 6.02 ± 0.7 | 7.08 ± 0.71 | 6.12 ± 0.9 |
Data are presented as mean ± SEM. Values with * are significantly (
Hematological indices in wistar rats administered
| Parameters | Groups | |||
|---|---|---|---|---|
| A | B | C | D | |
| WBCα | 6.46 ± 1.21 | 6.04 ± 1.24 | 6.02 ± 0.55 | 8.06 ± 1.34* |
| LYMPHβ | 71.62 ± 1.93 | 68.94 ± 2.06 | 69.54 ± 1.73 | 70.36 ± 1.58 |
| GRANβ | 18.50 ± 1.42 | 22.68 ± 1.69 | 20.18 ± 0.92 | 21.04 ± 1.40 |
| HGBμ | 8.80 ± 0.84 | 7.84 ± 0.98 | 7.64 ± 0.65 | 7.88 ± 0.50 |
| RBC€ | 0.34 ± 0.11 | 0.16 ± 0.01* | 0.14 ± 0.04* | 0.16 ± 0.01* |
| HCTβ | 2.50 ± 0.67 | 01.1 ± 0.07* | 1.06 ± 0.31* | 1.22 ± 0.07* |
| MPVa | 8.78 ± 0.10 | 8.60 ± 0.15 | 8.70 ± 0.11 | 8.62 ± 0.23 |
Data are presented as mean ± SEM. Values with * are significantly (
(1 × 109 cells/L),
g/dL,
%,
(1×1012 cells/L).
Liver mitochondrial membrane components and succinate dehydrogenase activity after 28 days administration of ethanolic extracts of
| Groups | SDH (U/mg protein) | Total protein (g/dL) | Cholesterol (mmol/L) | Phospholipid (mg/dL) |
|---|---|---|---|---|
| A | 0.8 ± 0.49 | 91.9 ± 6.21 | 134.4 ± 8.3 | 7.3 ± 1.11 |
| B | 2.8± 0.17* | 76.0 ± 6.02 | 205.5 ± 19.0 | 5.0 ± 1.55 |
| C | 3.1± 0.07* | 83.0 ± 5.83 | 151.4 ± 18.0 | 6.2 ± 1.70 |
| D | 3.0± 0.03* | 86.2 ± 6.43 | 111.8 ± 13 | 6.1 ± 2.55 |
Data are presented as mean ± SEM. Values with * are significantly (
Antioxidant parameters in the liver mitochondria of rats orally administered
| Groups | GSH (nmole/L) | SOD (U/mg protein) | CAT (U/mg protein) | MDA (nmole/L) |
|---|---|---|---|---|
| A | 2.1 ± 0.37 | 1.4 ± 0.16 | 19.7 ± 2.60 | 0.20 ± 0.03 |
| B | 2.2 ± 0.23 | 1.9 ± 0.47 | 16.6 ± 1.35 | 0.25 ± 0.04 |
| C | 1.8 ± 0.21 | 1.9 ± 0.22 | 23.3 ± 1.90 | 0.19 ± 0.03 |
| D | 2.5 ± 0.18 | 2.4 ± 0.58* | 23.7 ± 3.25 | 0.25 ± 0.03 |
Data are presented as mean ± SEM. Values with * are significantly (
Antioxidant parameters in the liver post mitochondrial fractions of rats orally administered
| Groups | GSH (nmole/L) | SOD (U/mg protein) | CAT (U/mg protein) | MDA (nmole/L) |
|---|---|---|---|---|
| A | 2.57 ± 0.30 | 5.34 ± 1.13 | 59 ± 7.42 | 0.57 ± 0.07 |
| B | 2.62 ± 0.41 | 4.16 ± 0.48 | 49 ± 4.23 | 0.53 ± 0.06 |
| C | 3.94 ± 1.61 | 4.84 ± 0.74 | 64.2 ± 6.36 | 0.73 ± 0.23 |
| D | 3.75 ± 1.26 | 8.62 ± 3.00* | 109.7 ± 35.56* | 1.03 ± 0.25* |
Data are presented as mean ± SEM. Values with * are significantly (
Antioxidant parameters in the kidney homogenate of rats orally administered
| Parameters | Groups | |||
|---|---|---|---|---|
| A | B | C | D | |
| GSHμ | 0.88 ± 0.08 | 1.06 ± 0.14 | 0.74 ± 0.09 | 0.92 ± 0.16 |
| SODα | 1.89 ± 0.23 | 1.72 ± 0.15 | 1.50 ± 0.06 | 1.43 ± 0.09 |
| CATα | 10.12 ± 1.55 | 12.32 ± 1.23 | 10.42 ± 1.82 | 10.56 ± 1.18 |
| MDAμ | 0.018 ± 0.00 | 0.027 ± 0.01* | 0.024 ± 0.01* | 0.30 ± 0.01* |
| PROTβ | 68.6 ± 6.35 | 54.6 ± 5.23 | 61.9 ± 2.93 | 63.4 ± 4.10 |
Data are presented as mean ± SEM. Values with * are significantly (
g/dL,
U/mgprot,
nmole/L.
CrossRef (0)
